DMIIU Drugs Made In America Acquisition II Corp.: institutional ownership and insider trading
12 funds reported holding $36.0M of Drugs Made In America Acquisition II Corp. in their latest 13F filings; in Q2 2026 funds net sold $9.21M, with 0 new positions and 3 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of DMIIU
- LMR Partners LLP — $20.3M
- Westchester Capital Management, LLC — $5.11M
- Verition Fund Management LLC — $2.54M
- BlueCrest Capital Management Ltd — $2.54M
- Walleye Capital LLC — $1.02M
- L1 Global Manager Pty Ltd — $1.02M
- READYSTATE ASSET MANAGEMENT LP — $1.02M
- HRT FINANCIAL LP — $1.01M
- MASO CAPITAL PARTNERS Ltd — $995K
- Rangeley Capital, LLC — $331K
Recent DMIIU insider trades
- Sep 26, 2025: Stockwell Lynn sold 7,966,667 shares ($0)
- Sep 26, 2025: Stockwell Lynn bought 700,000 shares ($0)
- Sep 26, 2025: Drugs Made In America Acquisition II LLC sold 7,966,667 shares ($0)
- Sep 26, 2025: Drugs Made In America Acquisition II LLC bought 700,000 shares ($0)
5%+ owners
- Drugs Made In America Acquisition II LLC: 10.2% (Schedule 13D, filed Oct 2, 2025)